SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
MAXY Analysis & Videos »
MAXY: Bull or Bear?
A biotech stock that you'll be glad you bought
MAXY
|
|
|
-14.81%
in
41 days
This stock is a rare bird. It's a biotech company with a real product and real earnings. They have no long-term debt and a lot of cash. The P/E under 4. Insiders own about a quarter of the company. They have a discipliined growth strategy, using joint ventures with larger,, better-capitalized partners in order to share costs and risks.
|
Maxygen Inc.
MAXY
|
|
|
+12.96%
in
491 days
Maxygen, Inc., a biotechnology company, engages in the discovery, development, and commercialization of protein pharmaceuticals for treatment of disease and serious medical conditions in the United States. The company’s product candidates comprises MAXY-G34, a granulocyte colony stimulating factor that is in Phase IIa clinical trial for the treatment of neutropenia; MAXY-VII, a factor VIIa product that is in pre-clinical stage for the treatment of hemophilia and acute bleeding conditions; and MAXY-4, a CTLA-4-Ig product for the treatment of rheumatoid arthritis and other immune or autoimmun< /><><><><><><>< /><><><><><><><><><><>< /><><><><><><><><><><><><><><><><><><><><><><><><>< />< /><><><><><><><><><><><>...
|
Bullish on MAXY ...
MAXY
|
|
|
+9.05%
in
6 days
(closed on 07/18/08)
Analysts' Recommendation: Buy 30 Days Ago: Strong Buy Analysts' Target: $11 Analysts' Targets Stanford Group Company $6 Buy Monday, June 16, 2008 MDB Capital Group $15 Buy Monday, January 07, 2008 Maxygen, Inc., a biotechnology company, engages in the discovery, development, and commercialization of protein pharmaceuticals for treatment of disease and serious medical conditions in the United States. The company’s product candidates comprises MAXY-G34, a granulocyte colony stimulating factor that is in Phase IIa clinical trial for the treatment of...
|
People Bullish on MAXY
People Bearish on MAXY
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
| StreetInsider.com on MAXY |
11% surge
- Shares of MAXY surged another 11% today on strong volume. We could see another day of gains before we get too overbought.. MACD in a strong up trend a
|
Breakout in progress
- Shares of MAXY continue to move higher as the stock breaks above its down trendline. Whilee the stock has enteredd overbought levels, the stochastics i...
|
Breakout in progress
- Shares of MAXY continue to move higher as the stock breaks above its down trendline. Whilee the stock has enteredd overbought levels, the stochastics i...
|
Breaking out
- Shares of MAXY are holding above the down trendline broken last Friday. The downside volume is considerably lighter than the upside volume and both th...
|
May be poised for a breakout
- After a three week consolidation, shares of MAXY are attempting to breakout from their trading range. The expanding volume and stochastics crossover fr...
|
More Resources
|
About Maxygen Inc.
- Answers.com
